Literature DB >> 20055846

Successful treatment of lichen amyloidosus associated with atopic dermatitis using a combination of narrowband ultraviolet B phototherapy, topical corticosteroids and an antihistamine.

N Oiso1, T Yudate, S Kawara, A Kawada.   

Abstract

Lichen amyloidosus (LA) is a type of primary localized cutaneous amyloidosis characterized by multiple pruritic discrete hyperkeratotic papules with amyloid deposition in the papillary dermis. Clinical regression is usually difficult to achieve, even after treatment. In this study, we report a case of an adult man with LA associated with atopic dermatitis (AD) which was successfully treated with narrowband ultraviolet B (NB-UVB) phototherapy, topical corticosteroids and an oral antihistamine. This case suggests that NB-UVB phototherapy may be a useful adjuvant for LA associated with AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20055846     DOI: 10.1111/j.1365-2230.2009.03574.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  4 in total

Review 1.  Pruritus: management algorithms and experimental therapies.

Authors:  Martin Steinhoff; Ferda Cevikbas; Akihiko Ikoma; Timothy G Berger
Journal:  Semin Cutan Med Surg       Date:  2011-06

2.  The topical application of low-temperature argon plasma enhances the anti-inflammatory effect of Jaun-ointment on DNCB-induced NC/Nga mice.

Authors:  Jeong-Hae Choi; Yeon-Suk Song; Hae-June Lee; Gyoo-Cheon Kim; Jin-Woo Hong
Journal:  BMC Complement Altern Med       Date:  2017-06-27       Impact factor: 3.659

Review 3.  Acquired hyperpigmentations.

Authors:  Tania Ferreira Cestari; Lia Pinheiro Dantas; Juliana Catucci Boza
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

4.  Generalized lichen amyloidosis and hyperthyroidism: coincidence or association.

Authors:  Müzeyyen Gönül; Seray Külcü Cakmak; Serra Kayaçatin
Journal:  Postepy Dermatol Alergol       Date:  2013-08-27       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.